Translate this page into:
Outcomes with Longterm Dual Antiplatelet Therapy After Coronary Angioplasty
This article was originally published by Thieme Medical and Scientific Publishers Private Ltd. and was migrated to Scientific Scholar after the change of Publisher; therefore Scientific Scholar has no control over the quality or content of this article.
Introduction: The optimal duration of dual antiplatelet therapy (DAPT) after drug-eluting stent (DES) implantation is an important, unanswered question. This study was designed to evaluate the association of varying durations of DAPT on clinical outcomes after DES implantation for the treatment of coronary artery disease.
Methods: Registry is maintained about the follow up of patients on DAPT therapy post percutaneous transluminal coronary angioplasty (PTCA) and the complications are noted in the follow up period between December 2015and May 2016 in NIMS hospital. Results were analyzed using appropriate Statistical tests.
Results: The number of evaluated patients was 127 with median age of 62 years. There were 27 females in them. Mean DAPT score was 1.68, with majority in the score range of one or two. Mean follow up period was 5.92 years (1 to 15 years). Among 127patients only 4 patients had complications, 3 of them had chronic stable angina and one had ischaemic stroke with no bleeding complication.
Conclusion: DAPT beyond one year has benefits in terms of low associated complications and low incidence of coronary events.